We are pleased to announce that we have obtained approval to sell our product in Australia. Our product has been registered as a Class I medical device.
Diagnocat receives Class I approval in Australia
Diagnocat
Aktualisiert: Januar 15, 2024
Veröffentlicht: Januar 15, 2024
Anmeldung zur Veranstaltung
Februar 27, 2025
17:00 Uhr
(CET)
Referent: Anton Demling
Prof. Dr.
Referent: Kai Meyer-Spradow
CEO medondo AG
Teilen
Das könnte Sie auch interessieren
Diagnocat
September 4, 2024
